SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Nektar Therapeutics (CA) Presents Positive Preclinical Data for NKTR-171, a Novel Sodium Channel Blocker to Treat Neuropathic Pain, at 41st Annual Meeting of the Society For Neuroscience